Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
            
  Top » Catalog » Journals » Journal of Pain Management » Volume 2 Issue 3 Articles » My Account  |  Cart Contents  |  Checkout   
Quick Find
  
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
Glyphosate: Chemistry, Uses and Safety Concerns
$95.00
Shopping Cart more
0 items
Information
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
Notifications more
NotificationsNotify me of updates to Efficacy of anodal transcranial direct current stimulation (tDCS) for the treatment of fibromyalgia: results of a randomized, sham-controlled longitudinal clinical trial (pp. 353-364)
Tell A Friend
 
Tell someone you know about this product.
Efficacy of anodal transcranial direct current stimulation (tDCS) for the treatment of fibromyalgia: results of a randomized, sham-controlled longitudinal clinical trial (pp. 353-364) $45.00
Authors:  (Angela Valle, Suely Roizenblatt, Sueli Botte, Soroush Zaghi, Marcelo Riberto, Sergio Tufik, Paulo S. Boggio and Felipe Fregni)
Abstract:
Fibromyalgia has been recognized as a central pain disorder
with evidence of neuroanatomic and neurophysiologic
alterations. Previous studies with techniques of noninvasive
brain stimulation--transcranial direct current stimulation
(tDCS) and repetitive transcranial magnetic stimulation
(rTMS)--have shown that these methods are associated with
a significant alleviation of fibromyalgia-associated pain and
sleep dysfunction. Here we sought to determine whether a
longer treatment protocol involving 10 sessions of 2 mA,
20 min tDCS of the left primary motor (M1) or dorsolateral
prefrontal cortex (DLPFC) could offer additional, more
long-lasting clinical benefits in the management of pain
from fibromyalgia. Methods: Forty-one women with
chronic, medically refractory fibromyalgia were
randomized to receive 10 daily sessions of M1, DLPFC, or
sham tDCS. Results: Our results show that M1 and DLPFC
stimulation both display improvements in pain scores
(VAS) and quality of life (FIQ) at the end of the treatment
protocol, but only M1 stimulation resulted in long-lasting
clinical benefits as assessed at 30 and 60 days after the end
of treatment. Conclusions: This study demonstrates the
importance of the duration of the treatment period,
suggesting that 10 daily sessions of tDCS result in more
long lasting outcomes than only five sessions. Furthermore,
this study supports the findings of a similarly designed
rTMS trial as both induce pain reductions that are equally
long-lasting. 


Available Options:
Version:
This Item Is Currently Unavailable.
Special Focus Titles
01.Laryngeal Cancer: Risk Factors, Symptoms and Treatment
02.Breast Surgery: Indications and Techniques
03.Cursed? Biologic and Cultural Aspects of the Menstrual Cycle and Menstruation
04.The Uses of Cocoa and Cupuaçu Byproducts in Industry, Health, and Gastronomy
05.Agriculture, Food, and Food Security: Some Contemporary Global Issues
06.Fungicides: Perspectives, Resistance Management and Risk Assessment
07.Current Developments in Alexithymia - A Cognitive and Affective Deficit
08.Political Concerns and Literary Topoi in French Grand Opera
09.Abdul Aziz Said: The Mualim, The Inspiration
10.Teachers and Teaching: Global Practices, Challenges, and Prospects
11.A Comprehensive Investigation on Executive-Employee Pay Gap of Chinese Enterprises: Antecedents and Consequences
12.American Alligators: Habitats, Behaviors, and Threats

Nova Science Publishers
© Copyright 2004 - 2018

Efficacy of anodal transcranial direct current stimulation (tDCS) for the treatment of fibromyalgia: results of a randomized, sham-controlled longitudinal clinical trial (pp. 353-364)